NEUROPROTECTIVE MECHANISM OF BEBERINE IN EXPERIMENTAL MODEL OF ALZHEIMER DISEASE: POSSIBLE BEHAVIORAL, BIOCHEMICAL AND CELLULAR ALTERATIONS

NEUROPROTECTIVE MECHANISM OF BEBERINE IN EXPERIMENTAL MODEL OF ALZHEIMER DISEASE: POSSIBLE BEHAVIORAL, BIOCHEMICAL AND CELLULAR ALTERATIONS

Bibliographic Details
Main Author:	Anil Kumar
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123009041

Similar Items

Microglial inhibitory mechanism of Coenzyme Q10 against Aβ (1-42) induced cognitive dysfunctions: possible behavioral, biochemical, cellular and histopathological alterations
by: Arti eSingh, et al.
Published: (2015-11-01)

Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer’s disease: a systematic review and meta-analysis
by: Lijuan Dan, et al.
Published: (2024-01-01)

Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease
by: Liting Song, et al.
Published: (2022-08-01)

Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
by: Xue Wang, et al.
Published: (2020-07-01)

Neuroprotective Effects of Carnosic Acid in an Experimental Model of Alzheimer’s Disease in Rats
by: Mohammad Taghi Joghataie, et al.
Published: (2011-01-01)

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
by: Goran Šimić, et al.
Published: (2016-01-01)

Possible Neuroprotective Mechanisms of Physical Exercise in Neurodegeneration
by: B. Mahalakshmi, et al.
Published: (2020-08-01)

Hidrox<sup>®</sup> Roles in Neuroprotection: Biochemical Links between Traumatic Brain Injury and Alzheimer’s Disease
by: Marika Cordaro, et al.
Published: (2021-05-01)

Neuroprotective Natural Products for Alzheimer’s Disease
by: Xin Chen, et al.
Published: (2021-05-01)

Neuroprotective Herbs for the Management of Alzheimer’s Disease
by: Julie Gregory, et al.
Published: (2021-04-01)

Neuroprotective Effect of Caffeine in Alzheimer’s Disease
by: Y Mukish M Yelanchezian, et al.
Published: (2022-06-01)

The Neuroprotective Potentiality of Flavonoids on Alzheimer’s Disease
by: Antonella Calderaro, et al.
Published: (2022-11-01)

Neuroprotective effects of resveratrol in Alzheimer’s disease
by: Yelluru Lakshmisha Rao, et al.
Published: (2020-01-01)

Impact of neuroprotection on incidence of Alzheimer's disease.
by: Raúl de la Fuente-Fernández
Published: (2006-01-01)

Alzheimer’s disease, neuroprotection, and CNS immunosenescence
by: Wolfgang J Streit, et al.
Published: (2012-07-01)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
by: Xue Wang, et al.
Published: (2020-09-01)

The Possible Neuroprotective Effect of Silymarin against Aluminum Chloride-Prompted Alzheimer’s-Like Disease in Rats
by: Hanaa R. Aboelwafa, et al.
Published: (2020-09-01)

Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease
by: Jiyoung Kim
Published: (2021-03-01)

Enrichment of novel Tau isoform with altered biochemical properties in Alzheimer’s disease
by: Chin-Tong Ong
Published: (2023-01-01)

Biochemical characterization of chamomile essential oil: Antioxidant, antibacterial, anticancer and neuroprotective activity and potential treatment for Alzheimer's disease
by: Nada F. Alahmady, et al.
Published: (2024-02-01)

Neuroprotection of phytic acid in Parkinson’s and Alzheimer’s disease
by: Yujie Chen, et al.
Published: (2023-11-01)

The emerging neuroprotective roles of exerkines in Alzheimer’s disease
by: Tayna Rody, et al.
Published: (2022-08-01)

Neuropeptides Exert Neuroprotective Effects in Alzheimer's Disease
by: Xin-Yi Chen, et al.
Published: (2019-01-01)

Neuroprotective effects of Resveratrol in Alzheimer Disease Pathology
by: Shraddha D Rege, et al.
Published: (2014-09-01)

The Neuroprotective Effect of L-Carnitine against Glyceraldehyde-Induced Metabolic Impairment: Possible Implications in Alzheimer’s Disease
by: Simona Magi, et al.
Published: (2021-08-01)

Study of neuroprotective activity of new acetylcholinesterase inhibitors TVA and TVS in experimental model of Alzheimer’s disease
by: Hrachik V. Gasparyan, et al.
Published: (2022-11-01)

Fucoidan serves a neuroprotective effect in an Alzheimer’s disease model
by: Mamangam Subaraja, et al.
Published: (2020-01-01)

Neuroprotection by Endoplasmic Reticulum Stress-Induced HRD1 and Chaperones: Possible Therapeutic Targets for Alzheimer’s and Parkinson’s Disease
by: Jun Nomura, et al.
Published: (2016-08-01)

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
by: Tiantian Guo, et al.
Published: (2020-07-01)

A review of the neuroprotective effects of andrographolide in Alzheimer's disease
by: Abedi, Zahra, et al.
Published: (2021)

The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment
by: Tarek Zieneldien, et al.
Published: (2022-02-01)

Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons
by: Jerònia eLladó, et al.
Published: (2013-10-01)

Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence
by: Ramit Sharma, et al.
Published: (2019-01-01)

Neuroprotective Effect of Quercetin Nanocrystal in a 6-Hydroxydopamine Model of Parkinson Disease: Biochemical and Behavioral Evidence
by: Fatemeh Ghaffari, et al.
Published: (2018-09-01)

Neuroprotective effects of epigallocatechin-3-gallate in an experimental model of Alzheimer’s disease in rat: a histological study
by: Homa Rassouli, et al.
Published: (2009-01-01)

Neuroprotective effects of epigallocatechin-3-gallate in an experimental model of Alzheimer’s disease in rat: a histological study
by: Homa Rassouli, et al.
Published: (2009-01-01)

Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
by: Huiqin Zhang, et al.
Published: (2021-07-01)

Move Your Body toward Healthy Aging: Potential Neuroprotective Mechanisms of Irisin in Alzheimer’s Disease
by: Tatiani Bellettini-Santos, et al.
Published: (2023-08-01)

Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease
by: Michał Wiciński, et al.
Published: (2020-04-01)

Research Progress on Neuroprotective Effects and Mechanisms of Glucagon-like Peptide 1 Analogues in Alzheimer's Disease
by: MEI Chenghan, et al.
Published: (2023-04-01)